Glenbrook Capital Buys Near 60% of Senestech Shares, Betting on Fertility‑Tech Growth Ahead of New Zealand Approval
Glenbrook Capital’s bulk purchases of Senestech shares show strong confidence in its fertility‑control tech, suggesting the stock may be undervalued and poised for growth.
3 minutes to read